Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
Tickers LXRX NEWS SHL SNY
Tags FDA General VTRS
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Tickers NEWS NVO REGN SNY
Tags News Large Cap SNY
From Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Tickers AMGN CMG GS LLY
Tags AMGN LLY GS
From Motley Fool
Why Sanofi Stock Flew Higher on Friday
Tickers SNY
Tags Recent Press Releases Market News SNY
From Motley Fool
Sanofi (SNY) Q3 2024 Earnings Call Transcript
Tickers SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
Tickers LLY NEWS REGN SNY
Tags REGN Briefs Benzinga
From Benzinga
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
Tickers AZN NEWS SNY
Tags Equities SNY Guidance
From Benzinga
Sanofi's Earnings Outlook
Tickers SNY
Tags Earnings Benzinga Market News
From Benzinga
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Tickers NEWS SNY
Tags M&A Market News Asset Sales
From Benzinga
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
Tickers NVAX SNY
Tags Market News NVAX Recent Press Releases
From Motley Fool
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Tickers NEWS NVS SNY
Tags NVS Market News Health Care
From Benzinga
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Tickers NEWS SNY
Tags General Briefs Biotech
From Benzinga
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Tickers NEWS SNY
Tags Market News M&A AI Generated
From Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Tickers BX GS GSK HLN
Tags BX Market News M&A
From Benzinga
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
Tickers DNLI NEWS SNY
Tags Danielle Brill Market News why it's moving
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers ABBV CSLLY GILD GSK
Tags dividend yield Price Target Expert Ideas
From Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
Tickers RHHBY RXRX SNY SOUN
Tags SNY RXRX Recent Press Releases
From Motley Fool
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Tickers CSLLY GSK NEWS SNY
Tags Market News Health Care GSK
From Benzinga
Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati
Tickers NEWS SNY
Tags Health Care Large Cap News
From Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Tickers AZN MRK NEWS NVO
Tags Briefs Benzinga Stories That Matter
From Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Tickers AZN LLY NEWS NVO
Tags Top Stories Regulations NVO
From Benzinga
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Tickers NEWS REGN SNY
Tags Market News why it's moving Top Stories
From Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
Tickers AMGN LLY NEWS SNY
Tags General Biotech Movers
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Tickers AMGN CGEM NEWS REGN
Tags News Large Cap SNY
From Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Tickers GS GSK HLN JNJ
Tags Market News M&A HLN
From Benzinga
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
Tickers NEWS SNY VTYX
Tags Market News Health Care Trading Ideas
From Benzinga
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
Tickers NEWS SNY
Tags Health Care Top Stories News
From Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
Tickers CI CVS LLY NEWS
Tags CVS SNY News
From Benzinga
Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows
Tickers NEWS SNY
Tags Large Cap News SNY
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags SNY News Briefs
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.